$87.44
0.51% day before yesterday
NYSE, Jun 06, 10:10 pm CET
ISIN
IE00BTN1Y115
Symbol
MDT

Medtronic Target price 2025 - Analyst rating & recommendation

Medtronic Classifications & Recommendation:

Buy
52%
Hold
42%
Sell
6%

Medtronic Price Target

Target Price $93.54
Price $87.44
Potential
Number of Estimates 24
24 Analysts have issued a price target Medtronic 2026 . The average Medtronic target price is $93.54. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 33 analysts: 17 Analysts recommend Medtronic to buy, 14 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medtronic stock has an average upside potential 2026 of . Most analysts recommend the Medtronic stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Apr '25 2026
Estimates
Revenue Billion $ 33.54 35.30
3.62% 5.26%
EBITDA Margin 25.41% 28.34%
5.26% 11.51%
Net Margin 13.90% 14.37%
22.39% 3.37%

28 Analysts have issued a sales forecast Medtronic 2026 . The average Medtronic sales estimate is

$35.3b
Unlock
. This is
5.26% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$35.8b 6.78%
Unlock
, the lowest is
$35.2b 4.95%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $33.5b 3.62%
2026
$35.3b 5.26%
Unlock
2027
$37.2b 5.27%
Unlock
2028
$39.0b 4.87%
Unlock
2029
$41.3b 5.98%
Unlock
2030
$43.1b 4.43%
Unlock

12 Analysts have issued an Medtronic EBITDA forecast 2026. The average Medtronic EBITDA estimate is

$10.0b
Unlock
. This is
18.39% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$10.3b 22.16%
Unlock
, the lowest is
$8.9b 5.80%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $8.5b 9.07%
2026
$10.0b 17.36%
Unlock
2027
$10.7b 6.87%
Unlock
2028
$11.7b 9.21%
Unlock
2029
$12.9b 10.42%
Unlock
2030
$13.9b 7.62%
Unlock

EBITDA Margin

2025 25.41% 5.26%
2026
28.34% 11.51%
Unlock
2027
28.77% 1.52%
Unlock
2028
29.96% 4.14%
Unlock
2029
31.21% 4.17%
Unlock
2030
32.16% 3.04%
Unlock

11 Medtronic Analysts have issued a net profit forecast 2026. The average Medtronic net profit estimate is

$5.1b
Unlock
. This is
8.78% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$6.9b 48.45%
Unlock
, the lowest is
$3.1b 33.20%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $4.7b 26.82%
2026
$5.1b 8.81%
Unlock
2027
$5.7b 12.88%
Unlock
2028
$6.4b 10.95%
Unlock
2029
$7.1b 11.29%
Unlock

Net Margin

2025 13.90% 22.39%
2026
14.37% 3.37%
Unlock
2027
15.41% 7.24%
Unlock
2028
16.30% 5.78%
Unlock
2029
17.12% 5.03%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Apr '25 2026
Estimates
Earnings Per Share $ 3.61 3.96
30.80% 9.70%
P/E 22.10
EV/Sales 3.73

11 Analysts have issued a Medtronic forecast for earnings per share. The average Medtronic EPS is

$3.96
Unlock
. This is
9.39% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$5.40 49.17%
Unlock
, the lowest is
$2.43 32.87%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $3.61 30.80%
2026
$3.96 9.70%
Unlock
2027
$4.47 12.88%
Unlock
2028
$4.96 10.96%
Unlock
2029
$5.52 11.29%
Unlock

P/E ratio

Current 24.15 17.77%
2026
22.10 8.51%
Unlock
2027
19.58 11.40%
Unlock
2028
17.64 9.91%
Unlock
2029
15.85 10.15%
Unlock

Based on analysts' sales estimates for 2026, the Medtronic stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.93 2.88%
2026
3.73 5.07%
Unlock
2027
3.54 5.01%
Unlock
2028
3.38 4.64%
Unlock
2029
3.19 5.64%
Unlock
2030
3.05 4.25%
Unlock

P/S ratio

Current 3.34 1.42%
2026
3.18 4.99%
Unlock
2027
3.02 5.01%
Unlock
2028
2.88 4.65%
Unlock
2029
2.72 5.64%
Unlock
2030
2.60 4.25%
Unlock

Current Medtronic Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Needham
Locked
Locked
Locked Jun 06 2025
RBC Capital
Locked
Locked
Locked May 22 2025
Baird
Locked
Locked
Locked May 22 2025
Mizuho
Locked
Locked
Locked May 22 2025
Needham
Locked
Locked
Locked May 22 2025
Needham
Locked
Locked
Locked May 19 2025
Truist Securities
Locked
Locked
Locked Apr 11 2025
Analyst Rating Date
Locked
Needham:
Locked
Locked
Jun 06 2025
Locked
RBC Capital:
Locked
Locked
May 22 2025
Locked
Baird:
Locked
Locked
May 22 2025
Locked
Mizuho:
Locked
Locked
May 22 2025
Locked
Needham:
Locked
Locked
May 22 2025
Locked
Needham:
Locked
Locked
May 19 2025
Locked
Truist Securities:
Locked
Locked
Apr 11 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today